Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet (Q36963194)

17 August 2017

1 reference

title

Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet (English)

1 reference

17 August 2017

0 references

Lawrence Steinman

1

1 reference

PubMed ID

17920547

17 August 2017

language of work or name

1 reference

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

4

1 reference

17 August 2017

4

1 reference

17 August 2017

661-665

1 reference

https://scigraph.springernature.com/pub.10.1016/j.nurt.2007.07.007

17 August 2017

0 references

cites work

Multiple sclerosis--the plaque and its pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Type II monocytes modulate T cell-mediated central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Design of effective immunotherapy for human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Myelin basic protein administration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Lipid microarrays identify key mediators of autoimmune brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.07.007

Paul Ehrlich and his Magic bullets--revisited.

21 January 2018

1 reference

12 December 2020

Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial

1 reference

12 December 2020

1 reference

12 December 2020

Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis

1 reference

12 December 2020

The coming of age for antigen-specific therapy of multiple sclerosis

1 reference

12 December 2020

Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand

1 reference

12 December 2020

Multiple sclerosis: a two-stage disease

1 reference

12 December 2020

Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms

1 reference

12 December 2020

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

12 December 2020

NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients

1 reference

12 December 2020

10.1016/J.NURT.2007.07.007

Identifiers

DOI

1 reference

PubMed ID

17920547

Dimensions Publication ID

17 August 2017

0 references

1 reference

PubMed ID

17920547